The recent use of oral contraceptives, particularly high-dose estrogen formulations, is associated with an increased risk for breast cancer, according to recent findings.
“Our results suggest that use of contemporary oral contraceptives in the past year is associated with an increased breast cancer risk relative to never or former oral contraceptive use, and that this risk may vary by oral contraceptive formulation,” researcher Elisabeth F. Beaber, PhD, MPH, of the public health sciences division of the Fred Hutchinson Cancer Research Center in Seattle, said in a press release.
Full Story »
Personalize your page!
Register for Healio to get content tailored to your specialty and areas of interest.
It’s FREE and only takes one minute.